@article{agulnik_open-label_2013,
	title = {An open-label, multicenter, phase {II} study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas},
	volume = {24},
	number = {1},
	journal = {Annals of Oncology},
	author = {Agulnik, Mark and Yarber, J. L. and Okuno, Scott Heitaka and Von Mehren, M. and Jovanovic, B. D. and Brockstein, B. E. and Evens, A. M. and Benjamin, R. S.},
	year = {2013},
	note = {Publisher: Oxford University Press},
	pages = {257--263},
}

{"_id":"rb6H7zGSH6Fh4hFh4","bibbaseid":"agulnik-yarber-okuno-vonmehren-jovanovic-brockstein-evens-benjamin-anopenlabelmulticenterphaseiistudyofbevacizumabforthetreatmentofangiosarcomaandepithelioidhemangioendotheliomas-2013","author_short":["Agulnik, M.","Yarber, J. L.","Okuno, S. H.","Von Mehren, M.","Jovanovic, B. D.","Brockstein, B. E.","Evens, A. M.","Benjamin, R. S."],"bibdata":{"bibtype":"article","type":"article","title":"An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas","volume":"24","number":"1","journal":"Annals of Oncology","author":[{"propositions":[],"lastnames":["Agulnik"],"firstnames":["Mark"],"suffixes":[]},{"propositions":[],"lastnames":["Yarber"],"firstnames":["J.","L."],"suffixes":[]},{"propositions":[],"lastnames":["Okuno"],"firstnames":["Scott","Heitaka"],"suffixes":[]},{"propositions":[],"lastnames":["Von","Mehren"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Jovanovic"],"firstnames":["B.","D."],"suffixes":[]},{"propositions":[],"lastnames":["Brockstein"],"firstnames":["B.","E."],"suffixes":[]},{"propositions":[],"lastnames":["Evens"],"firstnames":["A.","M."],"suffixes":[]},{"propositions":[],"lastnames":["Benjamin"],"firstnames":["R.","S."],"suffixes":[]}],"year":"2013","note":"Publisher: Oxford University Press","pages":"257–263","bibtex":"@article{agulnik_open-label_2013,\n\ttitle = {An open-label, multicenter, phase {II} study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas},\n\tvolume = {24},\n\tnumber = {1},\n\tjournal = {Annals of Oncology},\n\tauthor = {Agulnik, Mark and Yarber, J. L. and Okuno, Scott Heitaka and Von Mehren, M. and Jovanovic, B. D. and Brockstein, B. E. and Evens, A. M. and Benjamin, R. S.},\n\tyear = {2013},\n\tnote = {Publisher: Oxford University Press},\n\tpages = {257--263},\n}\n\n\n\n","author_short":["Agulnik, M.","Yarber, J. L.","Okuno, S. H.","Von Mehren, M.","Jovanovic, B. D.","Brockstein, B. E.","Evens, A. M.","Benjamin, R. S."],"key":"agulnik_open-label_2013","id":"agulnik_open-label_2013","bibbaseid":"agulnik-yarber-okuno-vonmehren-jovanovic-brockstein-evens-benjamin-anopenlabelmulticenterphaseiistudyofbevacizumabforthetreatmentofangiosarcomaandepithelioidhemangioendotheliomas-2013","role":"author","urls":{},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/Jonathan.Granek","dataSources":["uQKWSbSsGSxJRa4Sa","iNKrxdt4dmEjg2KeC"],"keywords":[],"search_terms":["open","label","multicenter","phase","study","bevacizumab","treatment","angiosarcoma","epithelioid","hemangioendotheliomas","agulnik","yarber","okuno","von mehren","jovanovic","brockstein","evens","benjamin"],"title":"An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas","year":2013}